Report Categories
View AllRecent Articles
View All
Indian Equity Markets Show Mixed Sentiment as Select BlueChips Outperform
Cambodian Opposition Leaders Partial Pardon Signals Potential Shift in Business Reputation
Mortgage Rates Show Mixed Movements as 30Year Fixed Declines and 15Year Rises
Rising Beef Costs Reshape Steakhouse Landscape
SP 500 Earnings and Revenue Growth Accelerates Says Oppenheimer
UUU Q4 2024 Earnings Widened Loss Amidst Challenging Market Conditions
RELL Q1 2026 Earnings EPS Surges Past Estimates Amid Mixed Market Sentiment
Omada Health Inc OMDA Q1 2026 Earnings Narrowerthanexpected Loss Boosts Investor Sentiment
KLAR Q1 2026 Earnings Significant EPS Beat as Losses Narrow Sharply
IDEX Corporation Q1 2026 Earnings EPS Surpasses Estimates by 117
Vita Coco Company COCO Advances 27 as Bullish Momentum Builds
Terns Pharmaceuticals TERN Holds Steady Near Support as Biotech Sector Watches for Catalysts
OFS Credit Company Inc OCCI Holds Near Key Support After Modest Decline
Sanofi SNY Holds Near Support Amid Modest Decline Key Levels in Focus
Shah Metacorp Surges on 498 Crore Rights Issue Eyes Renewable Energy Expansion
DOJs 68 Billion Enforcement Push Targets Nonprofit Fraud Highlighting 250M Minnesota Case
US Stock Futures Decline Bond Yields Fall on Reports of Putins Nuclear Doctrine Update
AI Capital Spending Boom Rivals Historic Peaks Raymond James Warns
External Links
SpaceX Faces A Crucial Launch Test Ahead Of Its IPO
VOXR Q1 2026 Earnings EPS Surges 733 Above Estimates Stock Declines 149
GGAL Q1 2026 Earnings EPS Misses Estimates Amid Challenging Argentine Macro Environment
ABX Q1 2026 Earnings EPS Meets Estimates but Stock Declines on Narrow Surprise
FPI Q1 2026 Earnings EPS Misses Estimates Amidst Agricultural Market Challenges
Cineverse Corp CNVS Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise Despite Revenue Challenges
IMNM Q1 2026 Earnings EPS Beat Partially Offsets Market Concerns
PRTH Q1 2026 Earnings EPS Surges 277 Above Estimates Shares Rally
Revvity Q1 2026 Earnings EPS Surpasses Consensus Stock Slips on Missing Revenue Details
Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline